(Q37617847)

21 August 2017

1 reference

title

Ependymoma: an update (English)

1 reference

21 August 2017

1 reference

1 reference

Stergios Zacharoulis

1

1 reference

21 August 2017

Lucas Moreno

series ordinal

2

1 reference

21 August 2017

publication date

1 November 2009

1 reference

Journal of Child Neurology

21 August 2017

published in

1 reference

21 August 2017

volume

24

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

1431-1438

1 reference

Metastatic ependymoma: a multi-institutional retrospective analysis of prognostic factors

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Radial glia cells are candidate stem cells of ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

The ATP binding cassette transporter A1 contributes to the secretion of interleukin 1beta from macrophages but not from monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Second-look surgery for incompletely resected fourth ventricle ependymomas: technical case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: a Childrens Cancer Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Chemotherapy for intracranial ependymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Ependymoma: a follow-up study of 101 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Intracranial ependymomas of childhood: long-term outcome and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Is gross-total resection sufficient treatment for posterior fossa ependymomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Ependymomas: results of radiation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Analyses of prognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Neuro-oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Intensity-modulated radiation therapy in childhood ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

CSF cytology has limited value in the evaluation of patients with ependymoma who have MRI evidence of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Intracranial ependymomas in childhood: recurrence, reoperation, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Treatment with oral etoposide for childhood recurrent ependymomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

The role of chemotherapy in newly diagnosed ependymoma of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Recurrent ependymoma treated with high-dose tamoxifen in a peripubertal female: Impact on tumor and the pituitary-ovarian axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Local radiotherapeutic management of ependymomas with fractionated stereotactic radiotherapy (FSRT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Adjuvant stereotactic radiosurgery for anaplastic ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Immunohistochemical markers for prognosis of ependymal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

alpha(v)beta(3) Integrin in central nervous system tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Expression of platelet-derived growth factor transcripts in medulloblastomas and ependymomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

Recurrent spinal ependymoma showing partial remission under Imatimib

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809339212

21 January 2018

Identifiers

DOI

10.1177/0883073809339212

1 reference

21 August 2017

1 reference